Stock Market News

4 days Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

PFE issues its financial guidance for 2025. MRK and ABBV announce M&A deals. SNY/TEVA’s IBD drug succeeds in a phase IIb study.

AbbVie (ABBV) · Merck&Co (MRK) · Pfizer (PFE)

4 hours Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

1 day Should Value Investors Buy Pfizer (PFE) Stock? Zacks

1 day Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

2 days Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

4 days MRK’s Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals Zacks

4 days Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know Zacks

4 days Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

5 days Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

5 days Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks

5 days Here’s Why VKTX Stock Plummeted 18% on Wednesday Zacks

6 days Merck (MRK) Stock Moves -1.72%: What You Should Know Zacks

6 days Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

6 days Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

6 days Merck’s BLA for RSV Antibody Clesrovimab Gets FDA Acceptance Zacks

6 days Merck to End Development of Two Cancer Candidates: Time to Sell? Zacks

6 days Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

6 days Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know Zacks

6 days Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

7 days Final Trade: GOOG, SAIA, X, PFE YouTube

7 days Pfizer climbs 4% on 2025 outlook YouTube

7 days Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

7 days Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

1 week Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

1 week Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

1 week Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

1 week Merck Ends Development of Two Experimental Cancer Drugs Zacks

1 week Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

1 week Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

1 week Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

1 week AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

1 week Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

1 week Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com

1 week Pfizer Sees 2025 Revenue in Line With Wall Street Views Yahoo Finance

1 week Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance

1 week Pfizer projects 2025 earnings to align with expectations Investing.com

1 week Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC

1 week Pfizer forecasts 2025 profit in line with expectations Investing.com

1 week These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance

1 week Stocks to Watch Recap: SoftBank, Pfizer, Super Micro, Affirm Yahoo Finance

1 week AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors Zacks

1 week AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors Seeking Alpha

1 week What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance

1 week CHMP Endorses Merck’s Kidney Cancer Drug for Two Indications Zacks

1 week ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks

1 week ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks

1 week Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha

1 week Pfizer: Irrational Anti-Vaccine Fear Seeking Alpha

1 week Is Pfizer a Millionaire Maker? Yahoo Finance

2 weeks Merck (MRK) Ascends While Market Falls: Some Facts to Note Zacks

2 weeks How Pfizer management outplayed activist investor Starboard Yahoo Finance

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.